Eagle Pharmaceuticals, Inc. (EGRX) Financials
EGRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 404.8 million | 152.8 million |
2023-03-31 | 414.2 million | 171.3 million |
2022-12-31 | 406.2 million | 172.6 million |
2022-09-30 | 390.1 million | 154.7 million |
EGRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -132000 | 4.2 million |
2023-03-31 | -33.6 million | 4.6 million |
2022-12-31 | 37.5 million | 4.1 million |
2022-09-30 | -13.2 million | 3.5 million |
EGRX Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-06-30 | 5.2 million |
2023-03-31 | 5.8 million |
2022-12-31 | 8.2 million |
2022-09-30 | -3.5 million |
EGRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 15.4 million | - | 1.4 million |
2023-03-31 | 21.9 million | - | 1.6 million |
2022-12-31 | 55.3 million | 56.2 million | 5.3 million |
2022-09-30 | 15.4 million | - | 3.4 million |
EGRX Shares Outstanding
EGRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 6000 | 9.8 million | 23.3 million | 4.4 million |
2023-03-31 | 58000 | 9.3 million | 24.3 million | 3.7 million |
2022-12-31 | 10000 | 7.2 million | 20.8 million | 3.4 million |
2022-09-30 | 10000 | 9.3 million | 21.8 million | 1.7 million |
EGRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 64.6 million | 16.9 million |
2023-03-31 | 66.3 million | 17.3 million |
2022-12-31 | 60.7 million | 19.9 million |
2022-09-30 | 65.9 million | 23.7 million |
EGRX
Price: $4.75
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.85 USD
P/E Ratio: 6.88
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 130600
Ebitda: 25.9 millionMarket Capitalization: 63.4 million